📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
72
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
60%
🔄 Reverse Split
65%
• 50-day avg $0.55 below $1 exchange minimum
• 10 months cash with weak price
🔁 Convertible Conversion
60%
• Major convertible overhang: 46% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
50%
• Score rose 49 points recently (worsening)
• Score in HIGH risk zone (75/100)
💹 Market Data
Market Cap$71.68M
Shares Outstanding128.01M
Float33.52M
Cash$19.34M
Debt$58.20M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 15.3% shares (2025Q4 vs prior)
7 institutional holders · 135.5K shares
#1
XTX Topco Ltd
48.7K shares
#2
RENAISSANCE TECHNOLOGIES LLC
35.5K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
20.3K shares
+ 4 more holders Sign up free to view →
📉 Short Interest
Short Interest64.5K
Days to Cover2.6
% of Float0.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 30, 2025
xbrl
XBRL CONVERTIBLE
Mar 31, 2025
424B3
ATM
Apr 30, 2026
424B3
ATM
Apr 30, 2026
6-K
8K EVENT
Apr 29, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GCL
📊 GCL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GCL Signal Convergence & Dark Pool Activity — StonkWhisper
📄 GCL Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.